NC
ELV icon

nVerses Capital’s Elevance Health ELV Stock Holding History

nVerses Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-200
Closed -$104K – 1057
2024
Q1 		$104K Buy
+200
New +$99.5K 0.25% 167

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

nVerses Capital's ELV Position: Q2 2024 in Review

nVerses Capital sold out of Elevance Health (ELV) in Q2 2024, closing a stake of 200 shares — an estimated $104K sold.

nVerses Capital first reported a position in ELV in Q1 2024 and held it in 1 quarter. The position peaked at $104K in Q1 2024. 1,705 funds tracked by Wall St. Rank hold ELV as of Q2 2024.

  • nVerses Capital reported no remaining Elevance Health position as of Q2 2024 after selling out during the quarter.
  • nVerses Capital sold 200 Elevance Health shares in Q2 2024, an estimated $104K.
  • nVerses Capital first reported a position in Elevance Health in Q1 2024 and held it in 1 quarter.
  • nVerses Capital's Elevance Health position peaked at $104K in Q1 2024.
  • 1,705 funds tracked by Wall St. Rank held Elevance Health as of Q2 2024.

Based on nVerses Capital's 13F filing for Q2 2024, filed 31 Jul 2024.